Cargando…
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631720/ https://www.ncbi.nlm.nih.gov/pubmed/26561512 http://dx.doi.org/10.1186/s12645-014-0004-8 |
_version_ | 1782398890386915328 |
---|---|
author | Le Duc, Géraldine Roux, Stéphane Paruta-Tuarez, Amandine Dufort, Sandrine Brauer, Elke Marais, Arthur Truillet, Charles Sancey, Lucie Perriat, Pascal Lux, François Tillement, Olivier |
author_facet | Le Duc, Géraldine Roux, Stéphane Paruta-Tuarez, Amandine Dufort, Sandrine Brauer, Elke Marais, Arthur Truillet, Charles Sancey, Lucie Perriat, Pascal Lux, François Tillement, Olivier |
author_sort | Le Duc, Géraldine |
collection | PubMed |
description | AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was evaluated in diluted conditions at physiological pH by dynamic light scattering and relaxometry. AGuIX nanoparticles are also known as positive contrast agents and efficient radiosensitizers. The aim of this paper is to compare their efficiency for magnetic resonance imaging and radiosensitization to those of the commercial gadolinium based molecular agent: DOTAREM®. An experiment with healthy animals was conducted and the MRI pictures we obtained show a better contrast with the AguIX compared to the DOTAREM® for the same amount of injected gadolinium in the animal. The better contrast obtained after injection of Aguix than DOTAREM® is due to a higher longitudinal relaxivity and a residential time in the blood circulation that is two times higher. A fast and large increase in the contrast is also observed by MRI after an intravenous injection of the AGuIX in 9 L gliosarcoma bearing rats, and a plateau is reached seven minutes after the injection. We established a radiotherapy protocol consisting of an irradiation by microbeam radiation therapy 20 minutes after the injection of a specific quantity of gadolinium. After microbeam radiation therapy, no notable difference in median survival time was observed in the presence or absence of gadolinium chelates (38 and 44 days respectively). In comparison, the median survival time is increased to 102.5 days with AGuIX particles showing their interest in this nanomedicine protocol. This remarkable radiosensitizing effect could be explained by the persistent tumor uptake of the particles, inducing a significant nanoscale dose deposition under irradiation. |
format | Online Article Text |
id | pubmed-4631720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-46317202015-11-09 Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment Le Duc, Géraldine Roux, Stéphane Paruta-Tuarez, Amandine Dufort, Sandrine Brauer, Elke Marais, Arthur Truillet, Charles Sancey, Lucie Perriat, Pascal Lux, François Tillement, Olivier Cancer Nanotechnol Research AGuIX nanoparticles are formed of a polysiloxane network surrounded by gadolinium chelates. They present several characteristics. They are easy to produce, they present very small hydrodynamic diameters (<5 nm) and they are biodegradable through hydrolysis of siloxane bonds. Such degradation was evaluated in diluted conditions at physiological pH by dynamic light scattering and relaxometry. AGuIX nanoparticles are also known as positive contrast agents and efficient radiosensitizers. The aim of this paper is to compare their efficiency for magnetic resonance imaging and radiosensitization to those of the commercial gadolinium based molecular agent: DOTAREM®. An experiment with healthy animals was conducted and the MRI pictures we obtained show a better contrast with the AguIX compared to the DOTAREM® for the same amount of injected gadolinium in the animal. The better contrast obtained after injection of Aguix than DOTAREM® is due to a higher longitudinal relaxivity and a residential time in the blood circulation that is two times higher. A fast and large increase in the contrast is also observed by MRI after an intravenous injection of the AGuIX in 9 L gliosarcoma bearing rats, and a plateau is reached seven minutes after the injection. We established a radiotherapy protocol consisting of an irradiation by microbeam radiation therapy 20 minutes after the injection of a specific quantity of gadolinium. After microbeam radiation therapy, no notable difference in median survival time was observed in the presence or absence of gadolinium chelates (38 and 44 days respectively). In comparison, the median survival time is increased to 102.5 days with AGuIX particles showing their interest in this nanomedicine protocol. This remarkable radiosensitizing effect could be explained by the persistent tumor uptake of the particles, inducing a significant nanoscale dose deposition under irradiation. Springer Vienna 2014-07-01 2014 /pmc/articles/PMC4631720/ /pubmed/26561512 http://dx.doi.org/10.1186/s12645-014-0004-8 Text en © Le Duc et al.; licensee Springer 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Le Duc, Géraldine Roux, Stéphane Paruta-Tuarez, Amandine Dufort, Sandrine Brauer, Elke Marais, Arthur Truillet, Charles Sancey, Lucie Perriat, Pascal Lux, François Tillement, Olivier Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title | Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title_full | Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title_fullStr | Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title_full_unstemmed | Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title_short | Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment |
title_sort | advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by mri for glioma treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631720/ https://www.ncbi.nlm.nih.gov/pubmed/26561512 http://dx.doi.org/10.1186/s12645-014-0004-8 |
work_keys_str_mv | AT leducgeraldine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT rouxstephane advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT parutatuarezamandine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT dufortsandrine advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT brauerelke advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT maraisarthur advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT truilletcharles advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT sanceylucie advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT perriatpascal advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT luxfrancois advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment AT tillementolivier advantagesofgadoliniumbasedultrasmallnanoparticlesvsmoleculargadoliniumchelatesforradiotherapyguidedbymriforgliomatreatment |